← Evidence map

ArticleRespiratory medicine case reports2017

EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50.

Paul Zarogoulidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2017

2018

2019

2020

2021

2022

this papercites it

EGFR or PD-L1 decision for first line therapy in a case series of EGFR positive and PD-L1 >50. | OpenQuestion